Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-06
2008-05-06
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000, C544S284000, C544S354000, C540S484000, C514S217060, C514S217090, C514S230500, C514S249000, C514S266210
Reexamination Certificate
active
07368445
ABSTRACT:
The disclosed invention is directed to compounds of the formula: Formula (I) and methods of using these compounds.
REFERENCES:
patent: WO 01/62756 (2001-08-01), None
patent: WO 02/094833 (2002-11-01), None
patent: WO 03/097639 (2003-11-01), None
patent: WO 2004/050659 (2004-06-01), None
Li Hong-Yu
McMillen William Thomas
Wang Yan
Eli Lilly and Company
Habte Kahsay T
Hostettler Danica
Tucker Tina M.
LandOfFree
Fused pyrazole derivatives as TGF-β signal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused pyrazole derivatives as TGF-β signal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused pyrazole derivatives as TGF-β signal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2805197